These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 23060790)
61. Antiviral Compounds from Myxobacteria. Mulwa LS; Stadler M Microorganisms; 2018 Jul; 6(3):. PubMed ID: 30029487 [TBL] [Abstract][Full Text] [Related]
62. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526 [TBL] [Abstract][Full Text] [Related]
63. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia. Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450 [TBL] [Abstract][Full Text] [Related]
64. Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity. Martinez MA; Nevot M; Jordan-Paiz A; Franco S J Virol; 2015 Oct; 89(19):9758-64. PubMed ID: 26178979 [TBL] [Abstract][Full Text] [Related]
65. Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients. Laguno M; Larrousse M; Blanco JL; Leon A; Milinkovic A; Martínez-Rebozler M; Loncá M; Martinez E; Sanchez-Tapias JM; de Lazzari E; Gatell JM; Costa J; Mallolas J AIDS Res Hum Retroviruses; 2008 Apr; 24(4):547-53. PubMed ID: 18393687 [TBL] [Abstract][Full Text] [Related]
66. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Tahaei SM; Mohebbi SR; Azimzadeh P; Vahedi M; Almasi S; Romani S; Sharifian A; Derakhshan F; Zali MR Hepat Mon; 2011 Dec; 11(12):993-6. PubMed ID: 22368684 [TBL] [Abstract][Full Text] [Related]
67. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [TBL] [Abstract][Full Text] [Related]
68. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Qiu L; Fan H; Jin W; Zhao B; Wang Y; Ju Y; Chen L; Chen Y; Duan Z; Meng S Biochem Biophys Res Commun; 2010 Aug; 398(4):771-7. PubMed ID: 20633528 [TBL] [Abstract][Full Text] [Related]
69. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management. De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285 [TBL] [Abstract][Full Text] [Related]
70. Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus. Gupta S; Malhotra B; Tiwari JK; Khandelwal PD; Maheshwari RK J Lab Physicians; 2018; 10(2):162-167. PubMed ID: 29692581 [TBL] [Abstract][Full Text] [Related]
71. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626 [TBL] [Abstract][Full Text] [Related]
72. Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injury. Liu B; Qian JM Int J Clin Exp Med; 2015; 8(11):19867-73. PubMed ID: 26884897 [TBL] [Abstract][Full Text] [Related]
73. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Hofmann WP; Soriano V; Zeuzem S Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206 [TBL] [Abstract][Full Text] [Related]
74. [Evaluation of viral hepatitis in solid organ transplantation]. Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153 [TBL] [Abstract][Full Text] [Related]
75. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana. Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687 [TBL] [Abstract][Full Text] [Related]
76. Inhibition of replication of porcine reproductive and respiratory syndrome virus by hemin is highly dependent on heme oxygenase-1, but independent of iron in MARC-145 cells. Wang L; Xiao S; Gao J; Liu M; Zhang X; Li M; Zhao G; Mo D; Liu X; Chen Y Antiviral Res; 2014 May; 105():39-46. PubMed ID: 24583029 [TBL] [Abstract][Full Text] [Related]
77. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714 [TBL] [Abstract][Full Text] [Related]